{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:24:00Z","timestamp":1781076240930,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["K08CA252637"],"award-info":[{"award-number":["K08CA252637"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000850","name":"National Heart and Lung Institute","doi-asserted-by":"publisher","award":["5T32HL120824-04"],"award-info":[{"award-number":["5T32HL120824-04"]}],"id":[{"id":"10.13039\/501100000850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","award":["TRP 6539-18"],"award-info":[{"award-number":["TRP 6539-18"]}],"id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["Max-Eder Program 70116606"],"award-info":[{"award-number":["Max-Eder Program 70116606"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009401","name":"Ludwig Maximilians University Munich | Medizinischen Fakult\u00e4t, Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","doi-asserted-by":"publisher","award":["Medical and Clinician Scientist Program (MSCP),"],"award-info":[{"award-number":["Medical and Clinician Scientist Program (MSCP),"]}],"id":[{"id":"10.13039\/501100009401","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer J."],"DOI":"10.1038\/s41408-025-01335-4","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T16:36:04Z","timestamp":1754325364000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Co-occurrence of clonally related follicular lymphoma and histiocytic sarcoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Sarah","family":"Haebe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra K.","family":"Czerwinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuja","family":"Sathe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Grimes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos J.","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brock","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanlee P.","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0694-3512","authenticated-orcid":false,"given":"Tanaya","family":"Shree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"key":"1335_CR1","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1080\/10428194.2018.1492128","volume":"60","author":"A Kommalapati","year":"2019","unstructured":"Kommalapati A, Tella SH, Go RS, Goyal G. Predictors of survival, treatment patterns, and outcomes in histiocytic sarcoma. Leuk Lymphoma. 2019;60:553\u20135.","journal-title":"Leuk Lymphoma"},{"key":"1335_CR2","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.5858\/arpa.2018-0220-RA","volume":"142","author":"SL Skala","year":"2018","unstructured":"Skala SL, Lucas DR, Dewar R. Histiocytic sarcoma: review, discussion of transformation from B-cell lymphoma, and differential diagnosis. Arch Pathol Lab Med. 2018;142:1322\u20139.","journal-title":"Arch Pathol Lab Med"},{"key":"1335_CR3","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.htct.2019.04.003","volume":"42","author":"G Deepa","year":"2020","unstructured":"Deepa G, Kamal V, Nandini V, Noaline S, Pande SC. Histiocytic sarcoma of the lymph node: a rare and aggressive hematolymphoid malignancy. Hematol Transfus Cell Ther. 2020;42:184\u20137.","journal-title":"Hematol Transfus Cell Ther"},{"key":"1335_CR4","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375\u201390.","journal-title":"Blood"},{"key":"1335_CR5","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S1470-2045(04)01428-7","volume":"5","author":"AL Feldman","year":"2004","unstructured":"Feldman AL, Minniti C, Santi M, Downing JR, Raffeld M, Jaffe ES. Histiocytic sarcoma after acute lymphoblastic leukaemia: a common clonal origin. Lancet Oncol. 2004;5:248\u201350.","journal-title":"Lancet Oncol"},{"key":"1335_CR6","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1038\/modpathol.2011.102","volume":"24","author":"H Shao","year":"2011","unstructured":"Shao H, Xi L, Raffeld M, Feldman AL, Ketterling RP, Knudson R, et al. Clonally related histiocytic\/dendritic cell sarcoma and chronic lymphocytic leukemia\/small lymphocytic lymphoma: a study of seven cases. Mod Pathol. 2011;24:1421\u201332.","journal-title":"Mod Pathol"},{"key":"1335_CR7","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1038\/leu.2014.167","volume":"28","author":"P Brunner","year":"2014","unstructured":"Brunner P, Rufle A, Dirnhofer S, Lohri A, Willi N, Cathomas G, et al. Follicular lymphoma transformation into histiocytic sarcoma: indications for a common neoplastic progenitor. Leukemia. 2014;28:1937\u201340.","journal-title":"Leukemia"},{"key":"1335_CR8","doi-asserted-by":"publisher","first-page":"5433","DOI":"10.1182\/blood-2007-11-124792","volume":"111","author":"AL Feldman","year":"2008","unstructured":"Feldman AL, Arber DA, Pittaluga S, Martinez A, Burke JS, Raffeld M, et al. Clonally related follicular lymphomas and histiocytic\/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone. Blood. 2008;111:5433\u20139.","journal-title":"Blood"},{"key":"1335_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.humpath.2016.04.004","volume":"55","author":"S Fernandez-Pol","year":"2016","unstructured":"Fernandez-Pol S, Bangs CD, Cherry A, Arber DA, Gratzinger D. Two cases of histiocytic sarcoma with BCL2 translocations and occult or subsequent follicular lymphoma. Hum Pathol. 2016;55:39\u201343.","journal-title":"Hum Pathol"},{"key":"1335_CR10","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1111\/bjh.17990","volume":"196","author":"S Haebe","year":"2022","unstructured":"Haebe S, Keay W, Alig S, Mohr AW, Martin LK, Heide M, et al. The molecular ontogeny of follicular lymphoma: gene mutations succeeding the BCL2 translocation define common precursor cells. Br J Haematol. 2022;196:1381\u20137.","journal-title":"Br J Haematol"},{"key":"1335_CR11","doi-asserted-by":"crossref","unstructured":"Zhao C, Pan Z. Histiocytic\/dendritic cell neoplasms: primary and transdifferentiated. In: Wang E, Lagoo AS, editors. Practical lymph node and bone marrow pathology: frequently asked questions. Cham: Springer International Publishing; 2020. pp. 345\u201354.","DOI":"10.1007\/978-3-030-32189-5_17"},{"key":"1335_CR12","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.clml.2018.10.004","volume":"19","author":"M Farris","year":"2019","unstructured":"Farris M, Hughes RT, Lamar Z, Soike MH, Menke JR, Ohgami RS, et al. Histiocytic sarcoma associated with follicular lymphoma: evidence for dramatic response with rituximab and bendamustine alone and a review of the literature. Clin Lymphoma Myeloma Leuk. 2019;19:e1\u20138.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"1335_CR13","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.path.2019.03.013","volume":"12","author":"Z Pan","year":"2019","unstructured":"Pan Z, Xu ML. Histiocytic and dendritic cell neoplasms. Surg Pathol Clin. 2019;12:805\u201329.","journal-title":"Surg Pathol Clin"},{"key":"1335_CR14","doi-asserted-by":"publisher","first-page":"650","DOI":"10.5858\/arpa.2018-0349-RS","volume":"144","author":"YP Hung","year":"2019","unstructured":"Hung YP, Qian X. Histiocytic sarcoma. Arch Pathol Lab Med. 2019;144:650\u20134.","journal-title":"Arch Pathol Lab Med"},{"key":"1335_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2023.100268","volume":"36","author":"A Ravindran","year":"2023","unstructured":"Ravindran A, Dasari S, Ruan GJ, Artymiuk CJ, He R, Viswanatha DS, et al. Malignant histiocytosis comprises a phenotypic spectrum that parallels the lineage differentiation of monocytes, macrophages, dendritic cells, and langerhans cells. Mod Pathol. 2023;36:100268.","journal-title":"Mod Pathol"},{"key":"1335_CR16","doi-asserted-by":"publisher","first-page":"7319","DOI":"10.1182\/bloodadvances.2022009349","volume":"7","author":"BH Durham","year":"2023","unstructured":"Durham BH, Hershkovitz-Rokah O, Abdel-Wahab O, Yabe M, Chung YR, Itchaki G, et al. Mutant PIK3CA is a targetable driver alteration in histiocytic neoplasms. Blood Adv. 2023;7:7319\u201328.","journal-title":"Blood Adv"},{"key":"1335_CR17","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1182\/blood.2023020360","volume":"142","author":"S Haebe","year":"2023","unstructured":"Haebe S, Day G, Czerwinski DK, Sathe A, Grimes SM, Chen T, et al. Follicular lymphoma evolves with a surmountable dependency on acquired glycosylation motifs in the B-cell receptor. Blood. 2023;142:2296\u2013304.","journal-title":"Blood"},{"key":"1335_CR18","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar S, Gonz\u00e1lez-Blas CB, Moerman T, Huynh-Thu VA, Imrichova H, Hulselmans G, et al. SCENIC: single-cell regulatory network inference and clustering. Nat Methods. 2017;14:1083\u20136.","journal-title":"Nat Methods"},{"key":"1335_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1084\/jem.20041535","volume":"201","author":"SL Nutt","year":"2005","unstructured":"Nutt SL, Metcalf D, D\u2019Amico A, Polli M, Wu L. Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors. J Exp Med. 2005;201:221\u201331.","journal-title":"J Exp Med"},{"key":"1335_CR20","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1182\/blood.2019001438","volume":"135","author":"Y Xiu","year":"2020","unstructured":"Xiu Y, Dong Q, Fu L, Bossler A, Tang X, Boyce B, et al. Coactivation of NF-\u03baB and Notch signaling is sufficient to induce B-cell transformation and enables B-myeloid conversion. Blood. 2020;135:108\u201320.","journal-title":"Blood"},{"key":"1335_CR21","volume":"14","author":"D Susan Joy Philip","year":"2022","unstructured":"Susan Joy Philip D, Sherief A, Narayanan G, Nair SG, Av J. Histiocytic sarcoma: clinical features and outcomes of patients treated at a tertiary cancer care center. Cureus. 2022;14:e25814.","journal-title":"Cureus"},{"key":"1335_CR22","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1056\/NEJMc1511490","volume":"378","author":"MM Gounder","year":"2018","unstructured":"Gounder MM, Solit DB, Tap WD. Trametinib in histiocytic sarcoma with an activating MAP2K1 (MEK1) mutation. N Engl J Med. 2018;378:1945\u20137.","journal-title":"N Engl J Med"},{"key":"1335_CR23","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41586-019-1012-y","volume":"567","author":"EL Diamond","year":"2019","unstructured":"Diamond EL, Durham BH, Ulaner GA, Drill E, Buthorn J, Ki M, et al. Efficacy of MEK inhibition in patients with histiocytic neoplasms. Nature. 2019;567:521\u20134.","journal-title":"Nature"},{"key":"1335_CR24","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1182\/blood.2020009855","volume":"137","author":"S Haebe","year":"2021","unstructured":"Haebe S, Shree T, Sathe A, Day G, Czerwinski DK, Grimes SM, et al. Single-cell analysis can define distinct evolution of tumor sites in follicular lymphoma. Blood. 2021;137:2869\u201380.","journal-title":"Blood"},{"key":"1335_CR25","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.leukres.2005.03.016","volume":"29","author":"MB Miranda","year":"2005","unstructured":"Miranda MB, Xu H, Torchia JA, Johnson DE. Cytokine-induced myeloid differentiation is dependent on activation of the MEK\/ERK pathway. Leuk Res. 2005;29:1293\u2013306.","journal-title":"Leuk Res"},{"key":"1335_CR26","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1182\/blood-2019-122286","volume":"134","author":"G Goyal","year":"2019","unstructured":"Goyal G, Abeykoon JP, Bennani NN, Liu MC, Shah MV, Go RS. Molecular alterations in adult histiocytic neoplasms. Blood. 2019;134:2975.","journal-title":"Blood"},{"key":"1335_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1127599","volume":"14","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Deng Y, Jiang Y, Zheng W, Tan Y, Yang Z, et al. Case report: Targeting the PD-1 receptor and genetic mutations validated in primary histiocytic sarcoma with hemophagocytic lymphohistiocytosis. Front Immunol. 2023;14:1127599.","journal-title":"Front Immunol"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-025-01335-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-025-01335-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-025-01335-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T13:54:40Z","timestamp":1757339680000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-025-01335-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1335"],"URL":"https:\/\/doi.org\/10.1038\/s41408-025-01335-4","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,4]]},"assertion":[{"value":"10 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The patient signed informed consent regarding to participate in the study. In addition, the patient signed informed consent to molecular analyses, publication of her data, and use of her imaging studies. The study was approved by the Institutional Review Board at Stanford University and conducted in accordance with good clinical practice (GCP) as defined in International Conference on Harmonization (ICH) guidelines and the US Code of Federal Regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"131"}}